Full Text View
Tabular View
No Study Results Posted
Related Studies
Pain Study of Rectus Muscle Closure at Cesarean Delivery
This study is currently recruiting participants.
Study NCT00505362   Information provided by Stanford University
First Received: July 19, 2007   Last Updated: July 20, 2007   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

July 19, 2007
July 20, 2007
June 2006
Post-operative pain [ Time Frame: Six weeks ]
Same as current
Complete list of historical versions of study NCT00505362 on ClinicalTrials.gov Archive Site
Post-operative adhesions [ Time Frame: Years: at time of repeat cesarean ]
Same as current
 
Pain Study of Rectus Muscle Closure at Cesarean Delivery
Rectus Muscle Closure vs. Non-Closure at Primary Cesarean Delivery and Post-Operative Pain

Suture reapproximation of the rectus muscles at primary cesarean delivery is a common practice about which there are no data. Some Obstetricians believe that suture reapproximation of the rectus muscles increases post-operative pain, and it may decrease adhesions, yet there are no published data to support or refute these claims. The purpose of this study is to assess the effect of rectus muscle reapproximation at cesarean delivery and post-operative pain. We also plan to assess the impact of rectus muscle closure on adhesions as seen at repeat cesarean delivery.

There are more than 1 million cesarean deliveries performed annually in the United States, at a rate of 30.2% of all deliveries. Data are limited regarding optimal surgical closure techniques to minimize adhesions at cesarean. Adhesions are implicated in pelvic pain, infertility, difficult repeat surgery, and bowel obstruction. Practice techniques regarding rectus muscle reapproximation vary widely, and there are no data regarding the impact of this step on pain, and some data suggesting a reduction in significant adhesions. Given the frequency of cesarean deliveries, small changes in surgical technique may yield significant benefits.

We hope to learn 1) whether suture reapproximation of the rectus muscles increases pain, and 2) the degree to which suture reapproximation of the rectus muscles alters adhesions when studied in a prospective, randomized trial.

All patients undergoing primary cesarean delivery at LPCH will be offered the study. Once consented, patients will be randomized to one of two standardized closure techniques at cesarean: two-layer uterine closure, peritoneal closure, fascial and skin closure, and either reapproximation of the rectus muscles with three-interrupted sutures, or non-closure. Intra-operative and post-operative pain management will be standardized. Subjects will undergo pain assessments while in-house on post-operative days 1 and 3, and at the standard post-partum clinic visit after 6 weeks. These assessments will require less than 5 minutes of the patient's time. Patients will be shown a pain chart, and will be asked to rate their pain on a scale of 0 to 10 at rest. They will then stand up and rate their pain again. Pain medication usage will also be assessed.

For patients who undergo repeat cesarean delivery, their surgeons will be asked to fill out a validated adhesion assessment form following surgery. We will not dictate the method of surgical technique at repeat cesarean, but will simply ask surgeons to describe the adhesions. At the time of consent, the patient will be asked to contact the study coordinator in the future should they undergo cesarean. In addition, the study coordinators will contact patients one-year after enrollment to inquire about plans for future pregnancies.

The surgeons will know the groups to which the patients are randomized. The patients and those collecting data on pain scores will not.

Phase II, Phase III
Interventional
Prevention, Randomized, Double-Blind, Uncontrolled, Parallel Assignment, Efficacy Study
  • Pain
  • Complications
  • Adhesions
Procedure: Suture reapproximation of the rectus muscles
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
112
December 2009
 

Inclusion Criteria:

  • 37 weeks gestation
  • Primary cesarean
  • ASA class 1 or class 2

Exclusion Criteria:

  • Chronic analgesia use
  • Vertical skin incision at cesarean
  • Opioid or NSAID allergy
  • BMI >40
  • Labor
Female
18 Years and older
Yes
Contact: Deirdre J Lyell, MD 650-736-1191 dlyell@stanford.edu
Contact: Jacqueline Laskey, BA 650-725-8623 jlaskey@lpch.org
United States
 
 
NCT00505362
 
 
Stanford University
 
Principal Investigator: Deirdre J Lyell, MD Lucile Packard Children's Hospital at Stanford University
Stanford University
July 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.